Coronavirus News and Research

RSS

Researchers test existing anti-inflammatory drug in COVID-19 patients

An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus.

29 Apr 2020

COVID tests are free, except when they’re not

Even before a novel virus swept around the world, Anna Davis Abel wore a mask to protect herself from getting sick.

29 Apr 2020

The challenges of keeping young adults safe during the pandemic

Last month, after California Gov. Gavin Newsom ordered most of the state's residents to stay home, I found myself under virtual house arrest with an uncomfortably large number of Gen Zers.

29 Apr 2020

BIOTECON Diagnostics releases microproof SARS-CoV-2 Screening/Identification Kits

BIOTECON Diagnostics has developed and launched its own microproof SARS-CoV-2 Screening/Identification Kits, which are available immediately for purchase and can be distributed globally.

29 Apr 2020

UEA Health Sciences students and staff respond to the fight against COVID-19

Following a nationwide call for support for the NHS workforce, UEA students and staff have responded in their numbers, from undertaking placements to training former healthcare professionals who are re-joining the service at this time of national emergency.

29 Apr 2020

GlobalData offers view on Gilead’s suspension of Covid-19 trials in China

Following the news that China trials of Gilead Sciences Inc’s antiviral drug remdesivir in patients with mild symptoms of coronavirus have been suspended due to lack of eligible patients;

From Gilead Sciences, Inc. 29 Apr 2020

Tapping into the powers of nature to identify virus killers

Many organisms have to defend themselves against predators, diseases or pests. Their metabolic products constitute a chemical arsenal that has been used for medical purposes since time immemorial.

29 Apr 2020

Study with twins shows COVID-19 symptoms have genetic contribution

A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.

29 Apr 2020

GlobalData: PPE shortage to drive adoption of robots to treat Covid-19 patients in India

Healthcare professionals are one of the most vulnerable groups exposed to infections. Rising number of coronavirus cases and severe shortage of personal protective equipment products across India are putting them at more risk.

29 Apr 2020

Study reveals SARS-CoV-2 RNA cap structure

A new study published on the preprint server bioRxiv in April 2020 reports the discovery of the structure of the cap created by the novel coronavirus on virally encoded mRNAs. The finding could help create new antiviral strategies.

29 Apr 2020

'Smart sample pooling' for COVID-19 could solve test kit shortage problem

A new study from Pakistan suggests 'smart sample pooling' using population grouping with algorithms as a solution to the unavailability of test kits for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a virus that causes COVID-19 disease. The paper is published on the preprint server medRxiv on April 28, 2020.

29 Apr 2020

How weather and demographics influence the COVID-19 spread

What can stop the spread of the novel coronavirus? A new study published in the preprint journal medRxiv in April 2020 debunks the idea that warmer and more humid conditions can hinder the pandemic from spreading with ease.

29 Apr 2020

How toxic are chloroquine and hydroxychloroquine to cells?

The spread of the pandemic disease COVID-19 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has now reached almost every country of the world, with over 3.11 million cases and over 217,000 deaths as of April 29, 2020.

29 Apr 2020

Study highlights biases and social implications in COVID-19 crisis

The biases individuals harbor against people they see as physically dirty emerge in children as young as five years old and persist into adulthood, according to a new study by researchers from Boston College and Franklin & Marshall College, who found these prejudices extend to the sick and may hold implications for people diagnosed with Covid-19.

29 Apr 2020

Men are twice more likely to die of COVID-19 than women

There have been studies that have revealed that men are more likely to get more severe symptoms from COVID-19 disease and also more likely to die from complications of the disease. A new study corroborates these findings. The study titled, “Gender differences in patients with COVID-19: Focus on severity and mortality,” is published in the latest issue of the journal Frontiers in Public Health.

29 Apr 2020

Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

28 Apr 2020

French scientists suggest nicotinic agonists could treat COVID-19

Contrary to the warnings issued by health agencies worldwide against cigarette smoking amid the coronavirus disease (COVID-19), a new paper suggests the possibility that nicotine, a component of tobacco, could prevent coronavirus infection.

28 Apr 2020

COVID-19 could be causing potentially fatal inflammatory disease in children, doctors warn

Since the emergence of the coronavirus disease (COVID-19) in China in December 2019, health experts have cautioned that the disease is particularly serious in high-risk populations, including older adults, those with underlying diseases, and those who are immunocompromised. Now, doctors in the United Kingdom warn of a rare and severe inflammatory disease in children with COVID-19.

28 Apr 2020

How hospitals can prepare for an influx of COVID-19 cases

Hospitals and healthcare systems worldwide are overwhelmed, with many facilities full of patients requiring emergency care for coronavirus disease (COVID-19) that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 disease causes severe respiratory illness in patients, with some needing mechanical ventilation.

28 Apr 2020

Exploring the use of stem cells for COVID-19 disease

The coronavirus disease (COVID-19) has ravaged across the, infecting more than 3.11 million people in just over four months. As the virus continues to spread, scientists are struggling to find an effective treatment for the infection. Now, a breakthrough discovery on stem cells could help in the battle against COVID-19.

28 Apr 2020